Assessment of Abuse
Potential of Drugs
Guidance for Industry
Additional copies are available from:
Office of Communications, Division of Drug Information,
Center for Drug Evaluation and Research,
Food and Drug Administration
th
10001New Hampshire Ave., Hillandale Bldg. 4
Floor
Silver Spring, MD 20993-0002
Phone: 855-543-3784 or 301-796-3400; Fax: 301-431-6353
Email: druginfo@fda.hhs.gov
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
January 2017
Clinical Medical